pillbase.ru

Adcetris

Active substance: brentuximab vedotin

Brentuximab vedotin

Centralised EU authorisationActive

Marketing holder: Takeda Pharma A/S

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
RU 2
  • Адцетрис®
    лиофилизат для приготовления концентрата для приготовления раствора для инфузий, 50 мг, 50 мг (original in Russian, GRLS)
    ЛП-003476
    Такеда Фарма А/С
  • Адцетрис®
    лиофилизат для приготовления концентрата для приготовления раствора для инфузий, 50 мг, 50 мг (original in Russian, GRLS)
    ЛП-№(001849)-(ГП-RU)
    Такеда Фарма А/С
US 1
  • ADCETRIS
    INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · BRENTUXIMAB VEDOTIN 50 mg/10.5mL
    51144-050
    SEAGEN INC.
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c3-2f8e-794b-b3bf-b23c568987a2,01a120c3-4380-7210-aeb4-97183bc99860;count=2 · valid from 2026-10-09 · verified 2026-10-09

  • United Statesprescription only

    Source: openFDA NDC · record 01a12091-bd61-7793-8eb2-5301238a5942;count=1 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/002455
Registration status
Active
ATC code
L01FX05
Sources
  • product · EMA · EMEA/H/C/002455 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/002455 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/002455 · Verified 2026-10-09